Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of... see more

TSXV:NU.H - Post Discussion

NeutriSci International Inc > Japan news coming soon according to this link
View:
Post by CanadianShark on Nov 11, 2020 11:23am

Japan news coming soon according to this link

https://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1fqnp0h-Bildschirmfoto%202020-11-11%20um%2014.15.46.png
Comment by Edcando on Nov 11, 2020 11:31am
Makes sense. They've been gushing demand awhile now and had their B2B launch last week. Gets some feedback and orders in from atttendees. Cross Is and dot Ts then get order in. 
Comment by CanadianShark on Nov 11, 2020 1:09pm
Hey Ed, will their next fins contain any revenue from Cryopharm at all? They should be released soon, right?  Or will the next one (q3) be the last fins with no revenue, and the one afterwards (q4) is the one we're waiting for? 
Comment by Edcando on Nov 11, 2020 2:00pm
I think fins have to be out 59-60 days after end of Q which would mean on it before Nov 30.  My best guess is that any of those revs will be on Q4 fins (like the sample order announced in Q2 going on Q3 fins because the product hadn't been "fulfilled " in Q2 (so I do expect $37,500 sample order on these next fins ). They stated launch of Cali tabs and marbie melts would be first ...more  
Comment by Edcando on Nov 11, 2020 2:01pm
Oops actually the $37,500 will also be on q4 fins. Stupid there's no edit feature here
Comment by ThatBigGinger on Nov 11, 2020 4:34pm
I cant find the NR , but didn't one of the semi recent ones state the sample order would be on Q3 fins? That or im slowly losing my mind.
Comment by CanadianShark on Nov 11, 2020 5:28pm
Yes, you are correct. It would be in this news release. Unless something changes that I am not aware of : https://stockhouse.com/news/press-releases/2020/08/31/neutrisci-provides-corporate-update-on-contract-partner-new-markets-and-product The Company would also like to clarify that pursuant to its revenue recognition policy, the revenue received from the initial sample order for Japan will be ...more  
Comment by Edcando on Nov 11, 2020 5:35pm
Yes "satisfies" lol. I knew it was a word like that lol. 
Comment by Edcando on Nov 11, 2020 5:34pm
Oops yes god damnit! Lol. The applicable NR stated that it would be in the Q(fill in the blank) because order hasn't been "full filled" or something in the Q  announced. Pretty sure now they announced the order in Q2 but didn't ship till early q3. I think the NR was shortly after Q2 fins explaining why it wasn't on there. Then I second guessed myself. Lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities